Approved by the Food and Drug Administration in January, Exubera is the first non-injectable insulin option in the United States since insulin delivery was introduced more than 80 years ago. It can be used to treat both Type 1 and Type 2 diabetes. Taken at mealtime, a patient breathes in normally through the mouth, sending the insulin into the lungs, where it is absorbed into the bloodstream. Because the lungs have a large and permeable surface area, they allow for rapid delivery of the insulin.
www.medequote.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment